FDA — authorised 19 March 2014
- Marketing authorisation holder: KNIGHT THERAPS
- Status: approved
🇺🇸 Impavido in United States
FDA authorised Impavido on 19 March 2014
Marketing authorisations
FDA — authorised 19 March 2014
- Application: NDA204684
- Marketing authorisation holder: KNIGHT THERAPS
- Local brand name: IMPAVIDO
- Indication: CAPSULE — ORAL
- Status: approved
Impavido in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in United States
Frequently asked questions
Is Impavido approved in United States?
Yes. FDA authorised it on 19 March 2014; FDA authorised it on 19 March 2014.
Who is the marketing authorisation holder for Impavido in United States?
KNIGHT THERAPS holds the US marketing authorisation.